Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys

European Journal of Pharmacology

Volumn 602, Issue 1, 2009, Pages 92-100

  Negus, S Stevens ^a,b   Bear, Ashley E ^a   Folk, John E ^a   Rice, Kenner C ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Antinociception; Delta opioid receptor; Efficacy; Interaction; Mu opioid receptor; Rhesus monkey

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; FENTANYL; MSF 61; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; NALTRINDOLE; SNC 243A; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FENTANYL; HOT TEMPERATURE; LIGANDS; MACACA MULATTA; NALTREXONE; PAIN; PAIN MEASUREMENT; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 57349192627     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.11.004     Document Type: Article

References (44)

1. Abdelhamid E.E., Sultana M., Portoghese P.S., and Takemori A.E. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258 (1991) 299-303
2. Adams J.U., Tallarida R.J., Geller E.B., and Adler M.W. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J. Pharmacol. Exp. Ther. 266 (1993) 1261-1267
3. Ananthan S. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics. Aaps J. 8 (2006) E118-E125
4. Brandt M.R., Furness M.S., Mello N.K., Rice K.C., and Negus S.S. Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity. J. Pharmacol. Exp. Ther. 296 (2001) 939-946
5. Cahill C.M., Morinville A., Hoffert C., O'Donnell D., and Beaudet A. Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101 (2003) 199-208
6. Calderon S.N., Rice K.C., Rothman R.B., Porreca F., Flippen-Anderson J.L., Kayakiri H., Xu H., Becketts K., Smith L.E., Bilsky E.J., Davis P., and Horvath R. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N ,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands. J. Med. Chem. 40 (1997) 695-704
7. Clark M.J., Emmerson P.J., Mansour A., Akil H., Woods J.H., Portoghese P.S., Remmers A.E., and Medzihradsky F. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. J. Pharmacol. Exp. Ther. 283 (1997) 501-510
8. Danielsson I., Gasior M., Stevenson G.W., Folk J.E., Rice K.C., and Negus S.S. Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys. Pharmacol. Biochem. Behav. 85 (2006) 428-434
9. Dykstra L.A., Bertalmio A.J., and Woods J.H. Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2 analysis. Psychopharmacol. Ser. 4 (1988) 107-121
10. Dykstra L.A., Granger A.L., Allen R.M., Zhang X., and Rice K.C. Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure. Psychopharmacology (Berl). 163 (2002) 420-429
11. Emmerson P.J., Liu M.R., Woods J.H., and Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J. Pharmacol. Exp. Ther. 271 (1994) 1630-1637
12. Emmerson P.J., Clark M.J., Mansour A., Akil H., Woods J.H., and Medzihradsky F. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J. Pharmacol. Exp. Ther. 278 (1996) 1121-1127
13. Furness M.S., Zhang X., Coop A., Jacobson A.E., Rothman R.B., Dersch C.M., Xu H., Porreca F., and Rice K.C. Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers. J. Med. Chem. 43 (2000) 3193-3196
14. Gerak L.R., Butelman E.R., Woods J.H., and France C.P. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J. Pharmacol. Exp. Ther. 271 (1994) 993-999
15. Gutstein H., and Akil H. Opioid analgesics. In: Brunton L., Lazo J., and Parker K. (Eds). The Pharmacological Basis of Therapeutics (2005), McGraw-Hill, New York 547-590
16. Heyman J.S., Jiang Q., Rothman R.B., Mosberg H.I., and Porreca F. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists. Eur. J. Pharmacol. 169 (1989) 43-52
17. Heyman J.S., Vaught J.L., Mosberg H.I., Haaseth R.C., and Porreca F. Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [d-Pen2, d-Pen5]enkephalin. Eur. J. Pharmacol. 165 (1989) 1-10
18. Jordan B.A., Cvejic S., and Devi L.A. Opioids and their complicated receptor complexes. Neuropsychopharmacology 23 (2000) S5-S18
19. Jutkiewicz E.M., Eller E.B., Folk J.E., Rice K.C., Traynor J.R., and Woods J.H. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. J. Pharmacol. Exp. Ther. 309 (2004) 173-181
20. Jutkiewicz E.M., Walker N.P., Folk J.E., Rice K.C., Portoghese P.S., Woods J.H., and Traynor J.R. Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats. J. Pharmacol. Exp. Ther. 312 (2005) 1314-1320
21. Kieffer B.L. Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides. Cell. Mol. Neurobiol. 15 (1995) 615-635
22. Lord J.A., Waterfield A.A., Hughes J., and Kosterlitz H.W. Endogenous opioid peptides: multiple agonists and receptors. Nature 267 (1977) 495-499
23. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., and Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197 (1976) 517-532
24. Morgan D., Cook C.D., and Picker M.J. Sensitivity to the discriminative stimulus and antinociceptive effects of mu opioids: role of strain of rat, stimulus intensity, and intrinsic efficacy at the mu opioid receptor. J. Pharmacol. Exp. Ther. 289 (1999) 965-975
25. Negus S.S. Sex and gonadal steroid hormone levels as determinants of opioid antinociception in rhesus monkeys. NIDA Res. Monogr. 182 (2002) 20-22
26. Negus S.S., Burke T.F., Medzihradsky F., and Woods J.H. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J. Pharmacol. Exp. Ther. 267 (1993) 896-903
27. Negus S.S., Butelman E.R., Chang K.J., DeCosta B., Winger G., and Woods J.H. Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. J. Pharmacol. Exp. Ther. 270 (1994) 1025-1034
28. Negus S.S., Gatch M.B., and Mello N.K. Effects of mu opioid agonists alone and in combination with cocaine and d-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology 18 (1998) 325-338
29. Negus S.S., Gatch M.B., Mello N.K., Zhang X., and Rice K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J. Pharmacol. Exp. Ther. 286 (1998) 362-375
30. Negus S.S., Schrode K., and Stevenson G.W. Mu/Kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability. Exp. Clin. Psychopharmacol. 16 (2008) 386-399
31. Patwardhan A.M., Berg K.A., Akopain A.N., Jeske N.A., Gamper N., Clarke W.P., and Hargreaves K.M. Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J. Neurosci. 25 (2005) 8825-8832
32. Portoghese P.S., Sultana M., and Takemori A.E. Naltrindole: A highly selective and potent non-peptide ∂ opioid-receptor antagonist. Eur. J. Pharmacol. 146 (1988) 185-186
33. Rothman R.B., and Xu H. Mu-delta interactions in vitro and in vivo. In: Chang K.-J., Porecca F., and Woods J.H. (Eds). The Delta Receptor (2004), Marcel Dekker, New York 373-400
34. Ruffolo Jr. R.R. Review important concepts of receptor theory. J. Auton. Pharmacol. 2 (1982) 277-295
35. Stevenson G.W., Linsenmayer D.C., Folk J.E., Rice K.C., and Negus S.S. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociceptionn. J. Pharmacol. Exp. Ther. 307 (2003) 1054-1064
36. Stevenson G.W., Folk J.E., Rice K.C., and Negus S.S. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[({alpha}R)-{alpha}-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)- 3-methoxybenzyl]-N,N-diethylbenzamide] and heroin. J. Pharmacol. Exp. Ther. 314 (2005) 221-231
37. Su Y.-F., McNutt R.W., and Chang K.-J. Delta-opioid ligands reverse alfentanil-induced respiratory depression but not antinociception. J. Pharmacol. Exp. Ther. 287 (1998) 815-823
38. Tallarida R.J. Drug synergism and dose-effect data analysis (2000), Chapman and Hall/CRC, Boca Raton, FL
39. Vaught J.L., and Takemori A.E. Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence. J. Pharmacol. Exp. Ther. 208 (1979) 86-90
40. Walker E.A., Butelman E.R., Decosta B.R., and Woods J.H. Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J. Pharmacol. Exp. Ther. 267 (1993) 280-286
41. Wessinger W.D. Approaches to the study of drug interactions in behavioral pharmacology. Neurosci. Biobehav. Rev. 10 (1986) 103-113
42. Woods J.H., Young A.M., and Herling S. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys. Fed. Proc. 41 (1982) 221-227
43. Woolverton W.L. Analysis of drug interactions in behavioral pharmacology. In: Thompson T., Dews P.B., and Barrett J.E. (Eds). Neurobehavioral Pharmacology (1987), Lawrence Erlbaum Associates, Hillsdale, NJ 275-302
44. Zhang X., Bao L., Arvidsson U., Elde R., and Hokfelt T. Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 82 (1998) 1225-1242